A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine in Children and Adolescents (MK-0462-082 AM7)

NCT01001234 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1382

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine, Acute

Interventions

DRUG: rizatriptan
DRUG: placebo
DRUG: rizatriptan
DRUG: placebo

Sponsor

Organon and Co